Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

HRTS vs. ETHSX: which is better?

Bottom line

HRTS vs ETHSX: the short answer

HRTS (Tema Heart & Health ETF) and ETHSX (Eaton Vance Worldwide Health Sciences Fund) are both etfs.

HRTS is cheaper at 0.75% vs 1.18% — a difference of $43 a year per $10,000 invested.

Over one year, HRTS returned +23.6% vs −1.9% for ETHSX (reporting dates differ).

ETHSX has a front-end sales load of up to 5.25%; the other does not.

Updated Nov 19, 2026

HRTS vs ETHSX side by side

HRTSETHSX
TypeETFMutual fund
Fund familyInnovatorMorgan Stanley
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.75%1.18%
Annual cost per $10k$75$118
10-yr cost on $10k (prospectus)$1,168$1,911
Max front loadNone5.25%
12b-1 fee0%0.25%
1-yr return+23.6%−1.9%
5-yr return (annualized)—+5.3%
10-yr return (annualized)—+6.4%
Best quarter+15.8%+14.2%
Worst quarter−12.4%−12.1%
Net assets (fund)$51.9M$757.9M
Number of holdings4542
Portfolio turnover4%3%
Returns as ofDec 31, 2025Dec 31, 2024

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearHRTSETHSXDifference
2024+3.6%+3.5%+0.1%

Source: Fund prospectus bar charts

Holdings overlap

14 of HRTS's top 25 holdings also appear in ETHSX's top 25.

Shared top holdings
HoldingHRTSETHSX
Eli Lilly & Co11.52%12.47%
UnitedHealth Group Inc5.24%5.49%
Novo Nordisk A/S5.24%1.71%
Merck & Co Inc4.27%5.08%
AstraZeneca PLC4.00%6.24%
Thermo Fisher Scientific Inc3.97%2.79%
Johnson & Johnson3.59%6.45%
Gilead Sciences Inc3.43%3.34%
Novartis AG3.38%1.65%
Vertex Pharmaceuticals Inc2.93%3.38%
Abbott Laboratories2.61%1.65%
AbbVie Inc2.40%6.46%
Bristol-Myers Squibb Co2.09%4.25%
Medtronic PLC1.88%1.80%

Source: SEC Form N-PORT

HRTS top 10

  1. Eli Lilly & Co — 11.52%
  2. UnitedHealth Group Inc — 5.24%
  3. Novo Nordisk A/S — 5.24%
  4. Roche Holding AG — 4.50%
  5. Merck & Co Inc — 4.27%
  6. AstraZeneca PLC — 4.00%
  7. Thermo Fisher Scientific Inc — 3.97%
  8. Johnson & Johnson — 3.59%
  9. Gilead Sciences Inc — 3.43%
  10. Novartis AG — 3.38%

ETHSX top 10

  1. Eli Lilly & Co — 12.47%
  2. AbbVie Inc — 6.46%
  3. Johnson & Johnson — 6.45%
  4. AstraZeneca PLC — 6.24%
  5. UnitedHealth Group Inc — 5.49%
  6. Roche Holding AG — 5.44%
  7. Merck & Co Inc — 5.08%
  8. Bristol-Myers Squibb Co — 4.25%
  9. Vertex Pharmaceuticals Inc — 3.38%
  10. Gilead Sciences Inc — 3.34%

FAQ

What is the difference between HRTS and ETHSX?
HRTS (Tema Heart & Health ETF) and ETHSX (Eaton Vance Worldwide Health Sciences Fund) are both etfs. HRTS is cheaper at 0.75% vs 1.18% — a difference of $43 a year per $10,000 invested.
Which is cheaper, HRTS or ETHSX?
HRTS has the lower expense ratio (0.75%).
Should I own both HRTS and ETHSX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.